Operating margin · 2016–2025
Bio-Techne operating margin
8.4%−53.0% · FY2025
Bio-Techne (TECH) reported 8.4% in operating margin for fiscal 2025, −53.0% year on year.
| Fiscal year | Operating margin | Change | Filing |
|---|---|---|---|
| FY2025 | 8.4% | −53.0% | Derived |
| FY2024 | 17.8% | −32.2% | Derived |
| FY2023 | 26.3% | −2.0% | Derived |
| FY2022 | 26.8% | +5.3% | Derived |
| FY2021 | 25.5% | +19.6% | Derived |
| FY2020 | 21.3% | +3.7% | Derived |
| FY2019 | 20.5% | −3.0% | Derived |
| FY2018 | 21.2% | −1.1% | Derived |
| FY2017 | 21.4% | −29.0% | Derived |
| FY2016 | 30.2% | — | Derived |
Operating margin — Operating margin is operating income divided by revenue. Only companies with at least $1 billion in revenue are ranked here.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth −13.3%
Calculated from two reported figures, so it has no single filing of its own.
Operating margin at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Bio-Techne operating margin |url=https://companiesranked.com/en/company/bio-techne/operating-margin |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Bio-Techne operating margin. CompaniesRanked. https://companiesranked.com/en/company/bio-techne/operating-marginBibTeX
@misc{companiesranked-en-company-bio-techne-operating-margin-2026,
author = {{CompaniesRanked}},
title = {{Bio-Techne operating margin}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/bio-techne/operating-margin}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.